By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trillium Therapeutics Inc. 

96 Skyway Avenue

Toronto  Ontario  M9W 4Y9  Canada
Phone: 416-595-0627 Fax: 416-595-5835




Company News
Trillium Therapeutics Inc. To Present At The 5th Annual Cancer Immunotherapy Conference 3/27/2015 6:57:33 AM
Trillium Therapeutics Inc. Announces Appointment of Eric L. Sievers, M.D. As Chief Medical Officer 3/27/2015 6:14:58 AM
Trillium Therapeutics Inc. To List Common Shares On The NASDAQ Capital Market Under The Symbol TRIL 12/18/2014 7:44:36 AM
Trillium Therapeutics Inc. Provides Corporate Update And Announces Reverse Stock Split For NASDAQ Listing 11/14/2014 7:23:14 AM
Trillium Therapeutics Inc.'s Anti-CD47 Oncology Program Highlighted in Prestigious Journal 9/7/2012 10:17:48 AM
Trillium Therapeutics Inc. Provides Update on Anti-CD47 Cancer Program 4/5/2012 8:52:47 AM
First Patient Treated in Trillium Therapeutics Inc.'s Interstitial Cystitis/Bladder Pain Syndrome Clinical Trial 3/28/2012 10:50:43 AM
Trillium Therapeutics Inc. to Commence Clinical Testing of TTI-1612 in Patients with Interstitial Cystitis/Bladder Pain Syndrome 12/15/2011 11:05:12 AM
Trillium Therapeutics Inc. Raises Funds to Advance Urology Program Into Clinical Trials 5/12/2011 7:17:10 AM
Trillium Therapeutics Inc.'s Cancer Stem Cell Program to be Highlighted at American Society of Hematology 12/2/2010 1:25:14 PM